Three-dimensional model of the ligand binding domain of the nuclear receptor for 1α,25-dihydroxy-vitamin D3

Journal of Cellular Biochemistry

Volumn 74, Issue 3, 1999, Pages 323-333

  Norman, Anthony W ^a   Adams, Derk ^b   Collins, Elaine D ^a,d   Okamura, William H ^b   Fletterick, Robert J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN JOSE STATE UNIVERSITY   (United States)

Author keywords

1 ,25(OH)2D3; Model; Nuclear receptor; Steroid receptor

Indexed keywords

CALCITRIOL; CELL NUCLEUS RECEPTOR; LIGAND; THYROID HORMONE RECEPTOR; VITAMIN D RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; HORMONE RECEPTOR INTERACTION; LIGAND BINDING; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; RAT; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL NUCLEUS; CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PROTEIN CONFORMATION; RATS; RECEPTORS, CALCITRIOL; SEQUENCE HOMOLOGY, AMINO ACID; VITAMIN D;

EID: 0033197920     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990901)74:3<323::AID-JCB2>3.0.CO;2-V     Document Type: Article

References (33)

1. Baudino TA, Kraichely DM, Jefcoat SC, Jr., Winchester SK, Partridge NC, MacDonald PN. 1998. Isolation and characterization of a novel coactivator protein, NCoA-62, involved in vitamin D-mediated transcription. J Biol Chem 273:16434-16441.
2. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharm 42:1569-1575.
3. Bouillon R, Okamura WH, Norman AW. 1995. Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257.
4. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D. 1995. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375:377-382.
5. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson J-A, Carlquist M. 1997. Molecular basis of agonism and antagonism of the oestrogen receptor. Nature 389:753-757.
6. Feng WJ, Ribeiro RC, Wagner RL, Nguyen H, Apriletti JW, Fletterick RJ, Baxter JD, Kushner PJ, West BL. 1998. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280:1747-1749.
7. 3 receptor zinc finger region. Mol Endocrinol 5:1815-1826.
8. Glass CK, Rose DW, Rosenfeld MG. 1997. Nuclear receptor coactivators. Curr Opin Cell Biol 9:222-232.
9. Hong H, Kohli K, Garabedian MJ, Stallcup MR. 1997. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17:2735-2744.
10. 3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription factor IIB, in vitro. J Biol Chem 272:14592-14599.
11. 3. J Clin Invest 92:12-16.
12. 3 analogues and their 20-epi homologues with the vitamin D receptor. J Biol Chem 272:3336-3345.
13. Malloy PJ, Eccleshall TR, Gross C, Van Maldergem L, Bouillon R, Feldman D. 1997. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. J Clin Invest 99:297-304.
14. Midland MM, Plumet J, Okamura WH. 1993. Effect of C20 stereochemistry on the conformational profile of the side chains of vitamin D analogs. Bioorg Med Chem Lett 3:1799-1804.
15. 3 receptor. J Biol Chem 271: 5143-5149.
16. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV. 1998. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptorgamma. Nature 395:137-143.
17. 3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis nor 6-s-trans locked analogs are preferred for genomic biological responses. Mol Endocrin 11:1518-1531.
18. Okamura WH, Palenzuela JA, Plumet J, Midland MM. 1992. Vitamin D: structure-function analyses and the design of analogs. J Cell Biochem 49:10-18.
19. 3 are associated with enhanced activation of the vitamin D receptor. J Biol Chem 270:10551-10558.
20. 3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev 12:1787-1800.
21. 3 receptor. In: Norman AW, Bouillon R, Thomasset M, editors. Vitamin D: Gene regulation, structure-function analysis and clinical application. Berlin: Walter de Gruyter. p 64-74.
22. Renaud J-P, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D. 1995. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689.
23. 3-resistant rickets in three families. Proc Natl Acad Sci USA 86:9783-9787.
24. Tanenbaum DM, Wang Y, Williams SP, Sigler PB. 1998. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci USA 95:5998-6003.
25. Thompson E, Kristjansson K, Hughes MR. 1991. Molecular scanning methods for mutation detection: application to the 1,25-dihydroxyvitamin D receptor. Eighth Workshop on vitamin D: Abstract book 6.
26. 3 analog with two side-chains. In: Norman AW, Bouillon R, Thomasset M, editors. Vitamin D: chemistry, biology and clinical applications of the steroid hormone. Riverside, CA: University of California-Riverside Printing & Reprographics, pp 19-23.
27. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ. 1995. A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697.
28. Whitfield GK, Hsieh JC, Nakajima S, MacDonald PN, Thompson PD, Jurutka PW, Haussler CA, Haussler MR. 1995. A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation. Mol Endocrinol 9:1166-1179.
29. 3. Point mutations confer reduced transactivation in response to ligand and impaire dinteraction with the retinoid X receptor heterodimeric partner. Mol Endocrinol 10:1617-1631.
30. Williams SP, Sigler PB. 1998. Atomic structure of progesterone complexed with its receptor. Nature 393:392-396.
31. Wurtz J-M, Guillot B, Moras D. 1997. 3D model of the ligand binding domain of the vitamin D nuclear receptor based on the crystal structure of holo RARγ. In: Norman AW, Bouillon R, Thomasset M, editors. Vitamin D: chemistry, biology and clinical applications of the steroid hormone. Riverside, CA: University of California-Riverside Printing and Reprographics, pp 165-172.
32. Wurtz J-M, Bourguet W, Renaud J-P, Chambon P, Moras D, Gronemeyer H. 1996. A canonical structure for the ligand-binding domain of nuclear receptors. Nature Struct Biol 3:87-94.
33. Yamada S, Yamamoto K, Masuno H, Ohta M. 1998. Conformation-function relationship of vitamin D: conformational analysis predicts potential side-chain structure. J Med Chem 41:1467-1475.